HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Russell, A. S. Articles by Lindstrom, J. M. Search for Related Content PubMed PubMed Citation Articles by Russell, A. S. Articles by Lindstrom, J. M.

Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor

Department of Medicine, University of Alberta, Edmonton, and The Salk Institute of Biological Studies, San Diego, California.

A woman with rheumatoid arthritis was treated with penicillamine and developed myasthenia gravis. This drug-induced disease was associated with characteristic autoantibodies to acetylcholine receptor. After discontinuing the drug, her symptoms improved and the antibody titers fell. Penicillamine is now being used much more frequently in the treatment of rheumatoid arthritis and it is likely that this complication will become more prevalent.

Dr. Lindstrom's address is Salk Institute of Biological Studies, P.O. Box 1809, San Diego, CA 921 12.

Accepted for publication August 12, 1977.

This article has been cited by other articles:

				A. K. Afifi and W. E. Bell Tests for Juvenile Myasthenia Gravis: Comparative Diagnostic Yield and Prediction of Outcome J Child Neurol, October 1, 1993; 8(4): 403 - 411. [Abstract] [PDF]